| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.50▲ | 3.36▲ | 3.36▲ | 3.08▲ | 3.10▲ |
| MA10 | 3.45▲ | 3.27▲ | 3.19▲ | 3.04▲ | 3.11▲ |
| MA20 | 3.34▲ | 3.12▲ | 3.10▲ | 3.01▲ | 3.03▲ |
| MA50 | 3.14▲ | 3.05▲ | 3.04▲ | 3.11▲ | 2.97▲ |
| MA100 | 3.07▲ | 3.03▲ | 3.02▲ | 3.02▲ | 3.13▲ |
| MA200 | 3.04▲ | 3.03▲ | 3.09▲ | 2.93▲ | 3.45▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | 0.043▲ | 0.053▲ | 0.039▲ | 0.016▲ |
| RSI | 85.026▲ | 86.456▲ | 82.368▲ | 71.323▲ | 62.018▲ |
| STOCH | 97.254▲ | 99.123▲ | 99.440▲ | 30.396 | 27.299 |
| WILL %R | -7.143▲ | -3.361▲ | -3.361▲ | -3.252▲ | -31.111 |
| CCI | 82.486 | 162.895▲ | 155.358▲ | 391.728▲ | 85.046 |
| ▲ PSAR&MOM | $ANIX PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&VOL | $ANIX RSI Cross Up and Volume | Set Alert |
| ▲ RSI | $ANIX RSI(14) Crossed Above 70 | Set Alert |
| RSI | $ANIX RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $ANIX MACD(12,26,9) Crossed Above Zero | Set Alert |
| MA | $ANIX Price Crossed Above MA(50) | Set Alert |
| MA | $ANIX Price Crossed Above MA(26) | Set Alert |
| MA | $ANIX Price Crossed Above MA(13) | Set Alert |
| MA | $ANIX Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $ANIX Open Gap Up %3 | Set Alert |
| ▲ GAP | $ANIX Open Gap Up %2 | Set Alert |
| ▲ BREAK | $ANIX Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $ANIX Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $ANIX Price Breaks 10 Days High | Set Alert |
|
Tuesday, September 09, 2025 03:45 PM
Investing in biotechnology stocks is typically reserved for speculative investors. For starters, many of these companies are clinical or pre-clinical stage companies. They’re not yet profitable, and ...
|
|
Monday, September 08, 2025 05:19 AM
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced it has completed dosing of the fourth ...
|
|
Tuesday, September 02, 2025 06:47 AM
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the time of management's presentation ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/09/25 | 3.08 | 3.54 | 3.03 | 3.52 | 563,859 |
| 12/09/25 | 2.96 | 3.03 | 2.93 | 2.94 | 102,200 |
| 11/09/25 | 3.04 | 3.04 | 2.93 | 2.95 | 92,600 |
| 10/09/25 | 3.02 | 3.09 | 2.95 | 3.02 | 168,800 |
| 09/09/25 | 3.04 | 3.04 | 2.95 | 2.98 | 43,344 |
| 08/09/25 | 3.01 | 3.03 | 2.98 | 2.98 | 53,155 |
| 05/09/25 | 3.00 | 3.00 | 2.94 | 2.97 | 36,400 |
| 04/09/25 | 2.98 | 3.07 | 2.93 | 2.97 | 42,600 |
| 03/09/25 | 3.14 | 3.14 | 2.95 | 2.99 | 92,908 |
| 02/09/25 | 2.96 | 3.20 | 2.96 | 3.09 | 88,064 |
|
|
||||
|
|
||||
|
|